Series A - Rezo Therapeutics
Investment Firm
Overview
Rezo Therapeutics identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence.
Announced Date
Nov 17, 2022
Funding Type
Series A
Highlights
Location
United States, North America
Social
Investor Lead
Norwest Venture Partners
Norwest Venture Partners is a convertible_note and debt and early_stage_venture and late_stage_venture and private_equity and secondary_market and venture firm.
Andreessen Horowitz
Andreessen Horowitz is a early_stage_venture and late_stage_venture and seed and venture firm.
SR One
SR One is a early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.
Participant Investors
9
Round Details and Background
Rezo Therapeutics raised $78000000 on 2022-11-17 in Series A
Rezo Therapeutics identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence.
Company Funding History
1
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Nov 17, 2022 |  Series A - Rezo Therapeutics | 9 | - | 78.0M |
Recent Activity
There is no recent news or activity for this profile.